Mammary Tumors and Mammary Tumor Virus Expression in Hybrid Mice of Strains C57BL and GR
Overview
General Medicine
Authors
Affiliations
Mammary tumorigenesis in genetic crosses between the high mammary tumor incidence GR and the low incidence C57BL mouse strains is highly correlated with murine mammary tumor virus expression in milk. Although the F1 and first backcross females had a mammary tumor incidence which was consistent with a single dominant gene segregation, the tumor incidence in the critical second backcross segregants disproved the single gene hypothesis. Genetic factors were clearly involved in regulation of virus expression which in turn correlated with both tumor incidence and tumor latency; these complex phenotypes are however best explained as threshold or quasicontinuous characters. As predicted from this model, the age specific incidence of mammary tumors showed a broad peak at 14-19 mo of age with no evidence of an early or late phase. Hematopoietic tumors showed no correlation with virus expression or mammary tumorigenesis suggesting different etiologies for these tumors.
Natural and induced immunity to mouse mammary tumors and the mammary tumor virus (MuMTV).
Stutman O Springer Semin Immunopathol. 1982; 4(4):333-72.
PMID: 6293110 DOI: 10.1007/BF02053739.
Etkind P, Szabo P, Sarkar N J Virol. 1982; 41(3):855-67.
PMID: 6284976 PMC: 256822. DOI: 10.1128/JVI.41.3.855-867.1982.
Nusse R, de Moes J, Hilkens J, VAN NIE R J Exp Med. 1980; 152(3):712-9.
PMID: 6251153 PMC: 2185924. DOI: 10.1084/jem.152.3.712.
Morris D, Young L, Gardner M, Cardiff R J Virol. 1986; 58(2):247-52.
PMID: 3009842 PMC: 252907. DOI: 10.1128/JVI.58.2.247-252.1986.
Hainaut P, Vaira D, Francois C, Calberg-Bacq C, OSTERRIETH P Arch Virol. 1985; 83(3-4):195-206.
PMID: 2982354 DOI: 10.1007/BF01309916.